Interleukin-31 Induces Itch-Related Responses with Precursor Behaviors in Mice and Its Suppression by the Dopamine D₂/D₃ Receptor Agonist Ropinirole
Abstract
Recent research has revealed that human itch manifests in a variety of distinct phenotypes, such as muzumuzu (creepy-crawly itch, a bit like tickling). We have also demonstrated that scratching behaviors induced by pruritogens in mice are sometimes preceded by specific precursor behaviors, such as shivering or forelimb grooming, whereas in other cases, these precursors are absent. These findings suggest that mice, like humans, exhibit characteristic itch-related behaviors. In the present study, we focused on interleukin-31 (IL-31), which has been implicated in atopic dermatitis-associated itch, and investigated whether precursor behaviors were observed during IL-31-induced itch-related behaviors in mice. Male ICR mice were used in this study. Following intradermal injection of IL-31, subsequent behaviors were recorded with a digital video camera, and scratch behaviors were counted based on the presence or absence of precursor behaviors. Intradermal IL-31-induced scratching with precursor behaviors was significantly higher than that without them. Dopamine D2 receptor agonists are reported to be effective against restless sensations. Ropinirole, a dopamine D2/D3 receptor agonist, significantly suppressed IL-31-induced scratching with precursor behaviors. Interestingly, ropinirole also attenuated IL-31-induced scratching without precursor behaviors. Histamine induces scratching that is unaccompanied by precursor behaviors compared to those accompanied by them. Ropinirole also inhibited histamine-induced scratching, both with and without precursor behaviors. In conclusion, these findings provide the first evidence that IL-31-induced itch-related responses are primarily characterized by precursor behaviors. Moreover, the fact that ropinirole significantly suppressed both IL-31- and histamine-induced scratching suggests that ropinirole holds therapeutic promise for managing diverse itch signaling pathways.
Related
- Galectins and the Interleukin-33/Suppression of Tumorigenicity-2 Pathway in First-episode Psychosis and Schizophrenia: A Cross-sectional Exploratory Study
- Aerobic exercise prevents neuroinflammation and ameliorates depressive-like behaviors via suppression of HMGB1/NF-κB pathway-mediated reactive microglial states in mice exposed to chronic mild stress
- Beyond Seizure Suppression: Caffeic Acid Phenethyl Ester and 10-Hydroxy-2-Decenoic Acid Improve Anxiety-like and Cognitive Behaviors in PTZ-Challenged Zebrafish.
- Light cycle phase and sex shape swimming exercise responses and stereotyped behaviors in mice
- Spartina anglica extract attenuates TNF-α/IFN-γ-induced inflammatory responses in HaCaT keratinocytes through suppression of the MAPK, NF-κB, and STAT1 signaling pathways
BibTeX
@article{andoh2026interleukin31,
title = {{Interleukin-31 Induces Itch-Related Responses with Precursor Behaviors in Mice and Its Suppression by the Dopamine D₂/D₃ Receptor Agonist Ropinirole}},
author = {Tsugunobu Andoh and Mami Suzuki},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = oct,
doi = {10.1248/bpb.b26-00468},
url = {https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00468/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Interleukin-31 Induces Itch-Related Responses with Precursor Behaviors in Mice and Its Suppression by the Dopamine D₂/D₃ Receptor Agonist Ropinirole
AU - Tsugunobu Andoh
AU - Mami Suzuki
PY - 2026
DA - 2026/10/24
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00468
UR - https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00468/_article
AB - Recent research has revealed that human itch manifests in a variety of distinct phenotypes, such as muzumuzu (creepy-crawly itch, a bit like tickling). We have also demonstrated that scratching behaviors induced by pruritogens in mice are sometimes preceded by specific precursor behaviors, such as shivering or forelimb grooming, whereas in other cases, these precursors are absent. These findings suggest that mice, like humans, exhibit characteristic itch-related behaviors. In the present study, we focused on interleukin-31 (IL-31), which has been implicated in atopic dermatitis-associated itch, and investigated whether precursor behaviors were observed during IL-31-induced itch-related behaviors in mice. Male ICR mice were used in this study. Following intradermal injection of IL-31, subsequent behaviors were recorded with a digital video camera, and scratch behaviors were counted based on the presence or absence of precursor behaviors. Intradermal IL-31-induced scratching with precursor behaviors was significantly higher than that without them. Dopamine D2 receptor agonists are reported to be effective against restless sensations. Ropinirole, a dopamine D2/D3 receptor agonist, significantly suppressed IL-31-induced scratching with precursor behaviors. Interestingly, ropinirole also attenuated IL-31-induced scratching without precursor behaviors. Histamine induces scratching that is unaccompanied by precursor behaviors compared to those accompanied by them. Ropinirole also inhibited histamine-induced scratching, both with and without precursor behaviors. In conclusion, these findings provide the first evidence that IL-31-induced itch-related responses are primarily characterized by precursor behaviors. Moreover, the fact that ropinirole significantly suppressed both IL-31- and histamine-induced scratching suggests that ropinirole holds therapeutic promise for managing diverse itch signaling pathways.
SN - 1347-5215
SN - 0918-6158
ER -